Tumour cell vaccines: has their time arrived.
D000818:Animals; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology; D007938:Leukemia / Q000517:prevention & control; D008285:Major Histocompatibility Complex / Q000235:genetics; D051379:Mice; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D009360:Neoplastic Cells, Circulating / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage*
D015395:Histocompatibility Antigens Class I; D007376:Interleukin-2; D014612:Vaccines